Influence of Nebivolol on Intracardiac Hemodynamics and Quality of Life in Patients with Chronic Heart Failure with Low Ejection Fraction

Abstract

This study assessed the effect of nebivalol on intracardiac hemodynamics, ejection fraction and quality of life in patients with chronic heart failure (CHF) stage II A and B, which developed against the background of coronary heart disease (CHD) and arterial hypertension (AH). This study was conducted on the basis of the Samarkand regional branch of the Republican Specialized Scientific and Practical Medical Center for Cardiology (SRF RSNPMCK ) for the period 2020-2022 The object of the study was 115 patients aged 45 to 78 years (55 men, 60 women) suffering from CHF II A and B stages . According to the results , it was found that in patients with CHF with low ejection fraction after treatment with nebiv a lol, an increase in intracardiac hemodynamics of TMZhP and STZ was noted, and this drug also had a beneficial effect on systolic and diastolic myocardial function, increased ejection fraction, exercise tolerance and reduces myocardial oxygen demand.